RxDoctor Payments Data

Angela Puckett, APRN

Psychiatric/Mental Health · Hawesville, KYNPI 1407258817

Payments from drug & device makers

$3,065in general payments, 2019–2025

Across 197 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$579
  • Johnson & Johnson$408
  • AbbVie$368
  • Lundbeck LLC$206
  • Takeda Pharmaceuticals U.S.A., Inc.$197
  • Neurocrine Biosciences, Inc.$174
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,065100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,065 in reported general payments places this provider in the 80th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$6,798
Medicare patients
25
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole59$111,279
IngrezzaValbenazine Tosylate13$95,502
VraylarCariprazine Hcl16$39,538
TrintellixVortioxetine Hydrobromide37$35,971
AuvelityDextromethorphan Hbr/Bupropion19$15,825
Aripiprazole76$12,736
AzstarysSerdexmethylphen/Dexmethylphen14$5,824
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine59$3,026
Thioridazine Hcl12$1,195
Atomoxetine Hcl14$1,189
Duloxetine Hcl35$846
Carbamazepine11$827
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$686
Quetiapine Fumarate38$659
Trazodone Hcl103$422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$90$111,27959 claims
Neurocrine Biosciences, Inc.Ingrezza$174$95,50213 claims
AbbVieVraylar$368$39,53816 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$197$35,97137 claims
Axsome Therapeutics, Inc.Auvelity$92$15,82519 claims
Corium, LLCAzstarys$579$5,82414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Hawesville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →